Search

Your search keyword '"Kaufman DS"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Kaufman DS" Remove constraint Author: "Kaufman DS"
250 results on '"Kaufman DS"'

Search Results

101. Global climate evolution during the last deglaciation.

102. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

103. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.

104. Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities.

105. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.

106. Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow.

107. A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells.

108. Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer.

109. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling.

110. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.

111. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.

112. Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells.

113. Methotrexate supports in vivo selection of human embryonic stem cell derived-hematopoietic cells expressing dihydrofolate reductase.

114. Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells.

115. HIF hits Wnt in the stem cell niche.

116. Use of human embryonic stem cells to understand hematopoiesis and hematopoietic stem cell niche.

117. Pluripotent stem cell-derived natural killer cells for cancer therapy.

118. Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer.

119. Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

120. In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase.

121. Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.

122. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

123. Recent warming reverses long-term arctic cooling.

124. Bladder cancer.

125. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?

126. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.

127. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.

128. Phase II study of sunitinib in men with advanced prostate cancer.

129. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.

130. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.

131. Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.

132. Hematopoietic differentiation of human embryonic stem cells by cocultivation with stromal layers.

133. Activation of hypoxic response in human embryonic stem cell-derived embryoid bodies.

134. Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls.

135. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells.

136. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

137. Closed-system behaviour of the intra-crystalline fraction of amino acids in mollusc shells.

138. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells.

139. Hematopoietic development of human embryonic stem cells in culture.

140. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.

141. Case records of the Massachusetts General Hospital. Case 18-2007. A 54-year-old man with early-stage prostate cancer.

142. Donor cell leukemia: insight into cancer stem cells and the stem cell niche.

143. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

144. Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer.

145. Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.

146. Bladder-sparing approaches to invasive disease.

147. Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation.

148. Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.

149. Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

150. Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy.

Catalog

Books, media, physical & digital resources